A capillary electrophoresis sequencing method for the identification of mutations in the inverted terminal repeats of adeno-associated virus

Human Gene Therapy Methods

Volumn 23, Issue 2, 2012, Pages 128-136

  Mroske, Cameron ^a   Rivera, Hector ^b   Ul Hasan, Taihra ^b   Chatterjee, Saswati ^b   Wong, K K ^a  

^a Division of Hematology   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGUANOSINE TRIPHOSPHATE; PLASMID DNA; VIRUS DNA; PRIMER DNA;

5' UNTRANSLATED REGION; ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DNA DENATURATION; DNA HAIRPIN; DNA SEQUENCE; GENE AMPLIFICATION; GENE CONSTRUCT; HUMAN; HUMAN CELL; INVERTED TERMINAL REPEAT; MOLECULAR CLONING; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RELIABILITY; SUBSTITUTION REACTION; VIRUS GENE; VIRUS MUTATION; VIRUS STRAIN; EVALUATION; GENE THERAPY; GENE VECTOR; GENETICS; INVERTED REPEAT; METHODOLOGY; RESTRICTION MAPPING;

ADENO-ASSOCIATED VIRUS;

DEPENDOVIRUS; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; ELECTROPHORESIS, CAPILLARY; GENETIC THERAPY; GENETIC VECTORS; INVERTED REPEAT SEQUENCES; RESTRICTION MAPPING;

EID: 84872046121     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2011.231     Document Type: Article

References (22)

1. Aravind, A., Schaffer, D.V., and Samulski, R.J. (2012). The AAV vector toolkit: Poised at the clinical crossroads. Mol. Ther. 20, 699-708.
2. Bainbridge, J.W., Smith, A.J., Barker, S.S., et al. (2008). Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 358, 2231-2239.
3. Chatterjee, S., Johnson, P.R., and Wong, K.K., Jr. (1992). Dualtarget inhibition of HIV-1 in vitro by means of an adenoassociated virus antisense vector. Science 258, 1485-1488.
4. Cideciyan, A.V., Aleman, T.S., Boye, S.L., et al. (2008). Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc. Natl. Acad. Sci. U.S.A. 105, 15112-15117.
5. Daya, S., and Berns, K.I. (2008). Gene therapy using adenoassociated virus vectors. Clin. Microbiol. Rev. 21, 583-593.
6. Feigin, A., Kaplitt, M.G., Tang, C., et al. (2007). Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 104, 19559- 19564.
7. Hauswirth, W.W., Aleman, T.S., Kaushal, S., et al. (2008). Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: Short-term results of a phase I trial. Hum. Gene Ther. 19, 979-990.
8. Henke, W., Herdel, K., Jung, K., et al. (1997). Betaine improves the PCR amplification of GC-rich DNA sequences. Nucleic Acids Res. 25, 3957-3958.
9. Inagaki, K., Ma, C., Storm, T.A., et al. (2007). The role of DNAPKcs and Artemis in opening viral DNA hairpin termini in various tissues in mice. J. Virol. 81, 11304-11321.
10. Kaplitt, M.G., Feigin, A., Tang, C., et al. (2007). Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: An open label, phase I trial. Lancet 369, 2097-2105.
11. Kieleczawa, J. (2006). Fundamentals of sequencing of difficult templates - an overview. J. Biomol. Tech. 17, 207-217.
12. Laughlin, C.A., Tratschin, J.D., Coon, H., and Carter, B.J. (1983). Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23, 65-73.
13. LeWitt, P., Rezai, A., Leehey, M., et al. (2011). AAV2-GAD gene therapy for advanced Parkinson's disease: A double-blind, sham-surgery controlled, randomised trial. Lancet Neurol. 10, 309-319.
14. Lusby, E., Fife, K.H., and Berns, K.I. (1980). Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. J. Virol. 34, 402-409.
15. Maguire, A.M., Simonelli, F., Pierce, E.A., et al. (2008). Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358, 2240-2248.
16. Michelfelder, S., and Trepel, M. (2009). Adeno-associated viral vectors and their redirection to cell-type specific receptors. Adv. Genet. 67, 29-60.
17. Mingozzi, F., and High, K. (2011). Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges. Nat. Rev. Genet. 12, 341-355.
18. Musso, M., Bocciardi, R., Parodi, S., et al. (2006). Betaine, dimethyl sulfoxide, and 7-deaza-dGTP, a powerful mixture for amplification of GC-rich DNA sequences. J. Mol. Diagn. 8, 544-550.
19. Nathwani, A.C., Tuddenham, E.G., Rangarajan, S., et al. (2011). Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 365, 2357-2365.
20. Samulski, R.J., Srivastava, A., Berns, K.I., and Muzyczka, N. (1983). Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV. Cell 33, 135-143.
21. Simonelli, F., Maguire, A.M., Testa, F., et al. (2010). Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol. Ther. 18, 643-650.
22. Wang, X.S., Ponnazhagan, S., and Srivastava, A. (1996). Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: Selective encapsidation of viral genomes in progeny virions. J. Virol. 70, 1668-1677.